lncRNA prostate cancer-associated transcript 18 upregulates activating transcription factor 7 to prevent metastasis of triple-negative breast cancer via sponging miR-103a-3p

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas, N. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61–70.
   PubMed Web of Science ®Google Scholar
• O’Brien KM, Cole SR, Tse CK, et al. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res. 2010;16(24):6100–6110.
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Satake H, Ishigaki S, et al. Kinetic volume analysis on dynamic contrast-enhanced MRI of triple-negative breast cancer: associations with survival outcomes. Br J Radiol. 2019;93(1106):20190712.
   PubMedGoogle Scholar
• Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15):4429–4434.
   PubMed Web of Science ®Google Scholar
• Kumar P, Aggarwal R. An overview of triple-negative breast cancer. Arch Gynecol Obstet. 2016;293(2):247–269.
   PubMed Web of Science ®Google Scholar
• Den Brok WD, Speers CH, Gondara L, et al. Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed. Breast Cancer Res Treat. 2017;161(3):549–556.
   PubMed Web of Science ®Google Scholar
• Kassam F, Enright K, Dent R, et al. Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design. Clin Breast Cancer. 2009;9(1):29–33.
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981.
   PubMed Web of Science ®Google Scholar
• Zhang HW, Zhang N, Liu Y, et al. Epigenetic regulation of NAMPT by NAMPT-AS drives metastatic progression in Triple-Negative Breast Cancer. Cancer Res. 2019;79(13):3347–3359.
   PubMed Web of Science ®Google Scholar
• Collina F, Aquino G, Brogna M, et al. LncRNA HOTAIR up-regulation is strongly related with lymph nodes metastasis and LAR subtype of Triple Negative Breast Cancer. J Cancer. 2019;10(9):2018–2024.
   PubMed Web of Science ®Google Scholar
• Li S, Zhou J, Wang Z, et al. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p. Biomed Pharmacother. 2018;104:451–457.
   PubMed Web of Science ®Google Scholar
• Chen P, Zhao X, Wang H, et al. The down-regulation of lncRNA PCAT18 promotes the progression of gastric cancer via MiR-107/PTEN/PI3K/AKT signaling pathway. Onco Targets Ther. 2019;12:11017–11031.
   PubMed Web of Science ®Google Scholar
• Crea F. Neuroendocrine prostate cancer: long noncoding RNAs to treat an incurable cancer - an interview with Dr Francesco Crea. Epigenomics. 2019;11(13):1461–1462.
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92–D97.
   PubMed Web of Science ®Google Scholar
• Gyorffy B, Lanczky A, Eklund AC, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123(3):725–731.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Takai H, Smogorzewska A, de Lange T. DNA damage foci at dysfunctional telomeres. Curr Biol. 2003;13(17):1549–1556.
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Oikawa T. Membrane lipids in invadopodia and podosomes: key structures for cancer invasion and metastasis. Oncotarget. 2010;1(5):320–328.
   PubMedGoogle Scholar
• Shin SJ, Kim J, Lee S, et al. Ulipristal acetate induces cell cycle delay and remodeling of extracellular matrix. Int J Mol Med. 2018;42(4):1857–1864.
   PubMed Web of Science ®Google Scholar
• Kitanaka N, Nakano R, Sakai M, et al. ERK1/ATF-2 signaling axis contributes to interleukin-1beta-induced MMP-3 expression in dermal fibroblasts. PLoS One. 2019;14(9):e0222869.
   PubMed Web of Science ®Google Scholar
• Igissinov N, Toguzbayeva A, Turdaliyeva B, et al. Breast cancer in megapolises of Kazakhstan: epidemiological assessment of incidence and mortality. Iran J Public Health. 2019;48(7):1257–1264.
   PubMed Web of Science ®Google Scholar
• Wein L, Loi S. Mechanisms of resistance of chemotherapy in early-stage triple negative breast cancer (TNBC). Breast. 2017;34(Suppl 1):S27–S30.
   PubMed Web of Science ®Google Scholar
• Dirix LY, Takacs I, Jerusalem G, et al. Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN solid tumor study. Breast Cancer Res Treat. 2018;167(3):671–686.
   PubMed Web of Science ®Google Scholar
• Foroughi K, Amini M, Atashi A, et al. Tissue-specific down-regulation of the long non-coding RNAs PCAT18 and LINC01133 in gastric cancer development. Int J Mol Sci. 2018;19(12):3881.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang H, Wang X, et al. PCAT18, as a novel differentially regulated long noncoding RNA in adult acute myeloid leukemia patients revealed by next-generation sequencing. Int J Lab Hematol. 2020;42(6):858–865.
   PubMed Web of Science ®Google Scholar
• Crea F, Watahiki A, Quagliata L, et al. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget. 2014;5(3):764–774.
   PubMed Web of Science ®Google Scholar
• Dou J, Tu DY, Zhao HJ, et al. LncRNA PCAT18/miR-301a/TP53INP1 axis is involved in gastric cancer cell viability, migration and invasion. J Biochem. 2020;168(5):547–555.
   PubMed Web of Science ®Google Scholar
• Yang D, Li R, Xia J, et al. Long noncoding RNA PCAT18 upregulates SPRR3 to promote colorectal cancer progression by binding to miR-759. Cancer Manag Res. 2020;12:11445–11452.
   PubMed Web of Science ®Google Scholar
• Gozdecka M, Breitwieser W. The roles of ATF2 (activating transcription factor 2) in tumorigenesis. Biochem Soc Trans. 2012;40(1):230–234.
   PubMedGoogle Scholar
• Guo HQ, Ye S, Huang GL, et al. Expression of activating transcription factor 7 is correlated with prognosis of colorectal cancer. J Cancer Res Ther. 2015;11(2):319–323.
   PubMed Web of Science ®Google Scholar
• van Dam H, Castellazzi M. Distinct roles of Jun: fos and Jun: ATF dimers in oncogenesis. Oncogene. 2001;20(19):2453–2464.
   PubMed Web of Science ®Google Scholar
• Li K, Wei L, Huang Y, et al. Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion. Int J Oncol. 2016;48(6):2479–2487.
   PubMed Web of Science ®Google Scholar
• Gokulnath M, Swetha R, Thejaswini G, et al. Transforming growth factor-beta1 regulation of ATF-3, c-Jun and JunB proteins for activation of matrix metalloproteinase-13 gene in human breast cancer cells. Int J Biol Macromol. 2017;94(Pt A):370–377.
   PubMedGoogle Scholar
• Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47–62.
   PubMed Web of Science ®Google Scholar
• Tang HX, Zhu DL, Zhang GZ, et al. AFAP1-AS1 promotes proliferation of pituitary adenoma cells through miR-103a-3p to activate PI3K/AKT signaling pathway. World Neurosurg. 2019;130:E888–E898.
   PubMed Web of Science ®Google Scholar
• Yu MJ, Xue YX, Zheng J, et al. Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway. Mol Cancer. 2017;16. DOI:10.1186/s12943-017-0677-9
   Web of Science ®Google Scholar
• He Q, Zhao L, Liu X, et al. MOV10 binding circ-DICER1 regulates the angiogenesis of glioma via miR-103a-3p/miR-382-5p mediated ZIC4 expression change. J Exp Clin Cancer Res. 2019;38(1):9.
   PubMedGoogle Scholar
• Zhong ZY, Lv MX, Chen JX. Screening differential circular RNA expression profiles reveals the regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in bladder carcinoma. Sci Rep. 2016;6:30919.
   Web of Science ®Google Scholar
• Hu X, Miao J, Zhang M, et al. miRNA-103a-3p promotes human gastric cancer cell proliferation by targeting and suppressing ATF7 in vitro. Mol Cells. 2018;41(5):390–400.
   PubMed Web of Science ®Google Scholar